British regulators are positive that a ban of metal-on-metal hip replacements from Johnson & Johnson and Stryker Corp. is necessary because of "unacceptably high" rates of follow-up operations.
The U.K's Medicines and Healthcare products Regulatory Agency say patients with a combination of Mitch TRH cup/heads made by Finsbury Orthopaedics, a unit of Johnson & Johnson and Accolade femoral stems manufactured by Stryker should be monitored closely. According to a patient registry, 10.7 percent of patients with the product combination underwent a second operation.
Metal-on-metal hip replacements have come under fire by researchers and regulators over the past couple of years after evidence of high failure rates and higher risk of exposure to toxic materials surfaced.
In the U.S., the Food and Drug Administration will meet June 27 to discuss safety concerns about various medical devices. If you think you have been harmed by a metal-on-metal hip replacement contact the Wade Yeoman at Jones Ward, PLC. He can be reached at 502-882-6000 or wade@jonesward.com
